WallStreetZenWallStreetZen

NASDAQ: GRTX
Galera Therapeutics Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

GRTX earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$59.1M
Current Profit Margin
0%

GRTX Return on Equity

Current Company
N/A
Current Industry
-63.5%
Current Market
188%

Be the first to know when GRTX announces earnings.

GRTX Return on Assets

Current Company
-137.5%
Current Industry
2.9%
GRTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

GRTX Return on Capital Employed

Current Company
-225.02%
Current Industry
19.5%
GRTX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GRTX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
GRTX$0.00-$47.41M-$59.08MN/AN/A
BCDA$477.00k-$11.16M-$11.57M-5.26%N/A
ONVO$242.00k-$18.82M-$19.09M-41.45%N/A
MBRX$0.00-$29.64M-$29.77MN/AN/A
KZIA$15.13kN/A-$10.33M-65.97%N/A
View Top Biotech Stocks

GRTX earnings dates

Next earnings date
Jun 13, 2024

Galera Therapeutics Earnings & Revenue FAQ

What were GRTX's earnings last quarter?

On Invalid Date, Galera Therapeutics (NASDAQ: GRTX) reported Q4 2023 earnings per share (EPS) of -$0.03, up 94.83% year over year. Total Galera Therapeutics earnings for the quarter were -$5.59 million. In the same quarter last year, Galera Therapeutics's earnings per share (EPS) was -$0.58.

If you're new to stock investing, here's how to buy Galera Therapeutics stock.

What was GRTX's earnings growth in the past year?

As of Q2 2024, Galera Therapeutics's earnings has grown year over year. Galera Therapeutics's earnings in the past year totalled -$59.08 million.

What is GRTX's earnings date?

Galera Therapeutics's earnings date is Invalid Date. Add GRTX to your watchlist to be reminded of GRTX's next earnings announcement.

What was GRTX's revenue last quarter?

On Invalid Date, Galera Therapeutics (NASDAQ: GRTX) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Galera Therapeutics's revenue was $0.00.

What was GRTX's revenue growth in the past year?

As of Q2 2024, Galera Therapeutics's revenue has grown null year over year. Galera Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.